Low-energy ketogenic therapy
Low-energy ketogenic therapy has been studied in 2 papers since 2025: 2 trials in people; 1 in the past year. The newest paper, Mar 29, 2026: “Short-Term Associations Between Fat-Free Mass Preservation and Glycaemic Markers During Tirzepatide Therapy: A Secondary Exploratory Analysis”.
2 papers study it2 findingsUpdated
See all 2 papers on low-energy ketogenic therapy
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“with the TZP+LEKT group achieving a greater FM loss (p = 0.042)”
None of its findings points the other way.
- 1 lab in 1 country
- Funders: European Commission and 1 more
- Human trial2
Studies in people
1 study gave low-energy ketogenic therapy to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases fat massgreater fat mass loss than TZP+LCD (p = 0.042) no change: Has no effect on body weight | Trial12 weeks | 60 peoplePatient cohorts | Nutrients, Mar 30, 2025 |
What did studies of low-energy ketogenic therapy find?
2Studies of low-energy ketogenic therapy measured 2 outcomes: body weight and fat mass.
Body weight
no changein humans1
1 study
Body weight
no changein humans1
Low-energy ketogenic therapy showed no clear effect on body weight in humans (combined with tirzepatide; compared with low-calorie diet).
Human trialcombined with tirzepatide; compared with low-calorie diet12 weeks
Fat mass
downin humans1
1 study
Fat mass
downin humans1
Low-energy ketogenic therapy decreases fat mass in humans (combined with tirzepatide; compared with low-calorie diet) (greater fat mass loss than TZP+LCD (p = 0.042)).
Human trialcombined with tirzepatide; compared with low-calorie diet12 weeks